Point-of-care Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Point of care Diagnostics Market is segmented by Product, End User (Hospitals/Critical Care Settings, Ambulatory Care Settings, Research Laboratories, and Other End Users), and Geography.

Point of Care Diagnostics Market Snapshot

Point of Care Diagnostics Market
Study Period:

2018 - 2026

Base Year:

2020

Fastest Growing Market:

Asia Pacific

Largest Market:

North America

CAGR:

9.8 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The point-of-care diagnostics market is expected to register a CAGR of 9.8%, over the forecast period. One of the major factors responsible for the growth of the market is the rising prevalence of chronic and infectious diseases in developing economies. The prevalence of chronic diseases, like diabetes, rheumatism, or cancer, is increasing globally, due to various reasons, such as an increase in the geriatric population, sedentary lifestyles, unhealthy food habits, and environmental factors. For instance, chronic diseases kill more than 38 million people each year, globally. Cardiovascular diseases account for most chronic disease deaths, or 17.5 million people, annually, followed by cancers (8.2 million), respiratory diseases (4 million), and diabetes (1.5 million). The aforementioned diseases account for 82% of all chronic disorder deaths. Point-of-care diagnostics is gaining wide acceptance by different patients across the world, as samples are collected from the patient’s location for performing tests, and the results can be achieved in very less time, due to the use of micro fluids, chips, and nano diagnostics.

Factors, such as the increasing number of regulatory approvals for novel immunoassay techniques, technological advancements, and the rising usage of home-based POC devices, are expected to drive the market growth, over the forecasted period.

Scope of the Report

Point-of-care testing diagnostics have many advantages, which allows patient diagnoses at many places, such as in the physician’s office, an ambulance, the home, the field, or in the hospital. The results of care are timely and offer rapid treatment to the patient.

Report scope can be customized per your requirements. Click here.

Key Market Trends

Blood Glucose Testing is Expected to Hold Major Revenue Share in the Type of Product Segment

Blood glucose testing point-of-care diagnostics captured the largest share in 2019, due to the success of hand-held glucose meters, owing to their high adoption rate among the population across the world. Periodic monitoring of glucose level is of vital importance for diabetic patients, which has encouraged the adoption of POC among diabetic patients in this segment. Other advantages associated with hand-held glucose meters are the portability and easy operability. The rising prevalence of diabetes across the world is expected to boost the segment growth in the future.

Point of Care Diagnostics Market

To understand key trends, Download Sample Report

North America Dominates the Market and is Expected to do Same in the Forecast Period

Currently, North America dominates the market for point-of care-diagnostics, and is expected to continue its stronghold for a few more years. In the North America region, the United States holds the largest market share. This can be majorly attributed due to the growing geriatric population base in the country, as well as the factors, such as the increasing prevalence of diseases and the favorable government regulations and initiatives undertaken for the development of healthcare infrastructure.

Point of Care Diagnostics Market

To understand geography trends, Download Sample Report

Competitive Landscape

The point-of-care diagnostics market is moderately competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. With rising prevalence of diseases and increasing number of aging population, other players are also expected to enter the market. Some of the major players of the market are Abbott, Siemens AG, Becton, Dickinson and Company, Johnson and Johnson, and F. Hoffmann-La Roche Ltd, among others.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Prevalence of Chronic and Infectious Diseases in Developing Economies

      2. 4.2.2 Increasing Number of Regulatory Approvals for Novel Immunoassay Techniques

      3. 4.2.3 Technological Advancements

      4. 4.2.4 Rising Usage of Home-based POC Devices

    3. 4.3 Market Restraints

      1. 4.3.1 Product Recalls by Major Players Demotivate New Entrants

      2. 4.3.2 Stringent Regulatory Policies and Reimbursement Issues

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Glucose Monitoring Kit

      2. 5.1.2 Cardio-metabolic Monitoring Kit

      3. 5.1.3 Pregnancy and Fertility Testing Kit

      4. 5.1.4 Infectious Disease Testing Kit

      5. 5.1.5 Cholesterol Test Strip

      6. 5.1.6 Hematology Testing Kit

      7. 5.1.7 Other Products

    2. 5.2 By End User

      1. 5.2.1 Hospital/Critical Care Setting

      2. 5.2.2 Ambulatory Care Setting

      3. 5.2.3 Research Laboratory

      4. 5.2.4 Other End Users

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle East & Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle East & Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott

      2. 6.1.2 Siemens AG

      3. 6.1.3 Beckman Coulter Inc.

      4. 6.1.4 Becton, Dickinson and Company

      5. 6.1.5 Instrumentation Laboratory

      6. 6.1.6 Johnson and Johnson

      7. 6.1.7 Nova Biomedical

      8. 6.1.8 Qiagen

      9. 6.1.9 F. Hoffmann-La Roche Ltd

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Point-of-care Diagnostics Market market is studied from 2018 - 2026.

The Point-of-care Diagnostics Market is growing at a CAGR of 9.8% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

  • Abbott
  • Siemens AG
  • Becton, Dickinson and Company
  • F. Hoffmann-La Roche Ltd
  • Qiagen

Are the major companies operating in Point-of-care Diagnostics Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!